The recommendations listed in this document are, whenever possible, evidence-based.
Unlike other ACC/AHA practice guidelines, there is not a large body of peer-reviewed …

The recommendations listed in this document are, whenever possible, evidence-based.
Unlike other ACC/AHA practice guidelines, there is not a large body of peer-reviewed …

Pulmonary hypertension remained an unexplained intractable disease with poor prognosis.
In the last 2 decades, however, the diagnosis and treatment methods for this disease …

Background—Although pulmonary thromboendarterectomy is increasingly successful for the
definitive treatment of chronic thromboembolic pulmonary hypertension (CTEPH), not all …

ISHLT members have recognized the importance of a consensus statement on the
evaluation and management of patients with chronic thromboembolic pulmonary …

Balloon pulmonary angioplasty for inoperable chronic thrombo... : Current Opinion in Pulmonary
Medicine Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary …

In chronic thromboembolic pulmonary hypertension (CTEPH), stenoses or obstructions of
the pulmonary arteries due to organized thrombi can cause an elevation in pulmonary artery …

Background Peripheral pulmonary arterial stenosis (PPAS) in childhood is frequently
associated with other syndromes; however, PPAS in adolescents and adults is rare and its …

Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by mechanical
obstruction of large pulmonary arteries secondary to one or more episodes of pulmonary …

Balloon pulmonary angioplasty (BPA) is a novel technique for the treatment of chronic
thromboembolic pulmonary hypertension. While cardiologists need no introduction to the …